← Back to Search

Patients with chronic back pain with lumbar, cervical or thoracic spine diagnoses. for Chronic Back Pain

N/A
Recruiting
Led By Chinwe Nwaneshiudu
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 12 months
Awards & highlights

Study Summary

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.

Eligible Conditions
  • Chronic Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Current Opioid misuse measure (COMM) surveys
Screener and Opioid Assessment for patients with pain revised (SOAPPR)
Secondary outcome measures
Pain Intensity with Brief Pain inventory (BPI)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with chronic back pain with lumbar, cervical or thoracic spine diagnoses.Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
858 Previous Clinical Trials
524,156 Total Patients Enrolled
Chinwe NwaneshiuduPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Chinwe Nwaneshiudu 2023. "Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06288282.
All > New York City > Philadelphia
~76 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top